From DCAT Value Chain Insights (VCI)
CMC Biologics, a contract biologics manufacturing organization, has appointed Joseph Wypych as general manager of its Seattle facility. Mr. Wypych will manage site operations of CMC Biologics’ clinical and commercial manufacturing facility.
Mr. Wypych brings more than 20 years of biopharmaceutical industry expertise in process development and manufacturing. Prior to CMC Biologics, he served as plant manager at Baxter Bioscience, Hayward, California. Previously, he held manufacturing and supply-chain project management positions at ImClone Systems and Cell Genesys Inc., respectively.
Source: CMC Biologics
Thank you for reading DCAT Value Chain Insights (VCI), an information resource from the
Drug, Chemical & Associated Technologies Association (DCAT).
Learn more and sign up to receive a complimentary subscription